Liver Failure, Acute: Clinical Trials

7 trials for Liver Failure, Acute, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed. 7 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 17Completed 7
Phase 23Completed 3

Follow Liver Failure, Acute: new trials by email Literature Review of Liver Failure, Acute trials Research Report on Liver Failure, Acute

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacokinetic Study on G1090N (Nitazoxanide) Capsules in Healthy Volunteers
Single Dose G1090N, Multiple dosing of G1090N - Acute-on-Chronic Liver Failure
Phase 1CompletedGenfit522025-08-262026-01-16
miroliverELAP® for the Treatment of Acute Liver Failure: A Phase 1 Trial
miroliverELAP treatment - Acute Liver Failure, Acute Liver Injury, Drug Induced
Phase 1CompletedMiromatrix Medical Inc.102024-10-052026-03-06
Efficacy and Safety of BMSCs (CG-BM1) for ACLF Patients
Bone marrow mesenchymal stem cells (low dose), Solvent of CG-BM1, Bone marrow mesenchymal stem cells (medium dose) - Acute-On-Chronic Liver Failure
Phase 1 / Phase 2CompletedGuangZhou Cellgenes Biotechnology Co., Ltd.1002023-03-012026-10-21
Intravenous BCAA for HE in ACLF (BCAA-HE-ACLF)
Branch Chain Amino Acid, Lactulose - Hepatic Encephalopathy, Acute-On-Chronic Liver Failure
Phase 1CompletedPost Graduate Institute of Medical Education and Research, Chandigarh1142023-01-172025-06-08
Intravenous Branched Chain Amino Acids for Hepatic Encephalopathy in ACLF
Branched chain amino acid, Lactulose - Hepatic Encephalopathy, Acute-On-Chronic Liver Failure
Phase 1CompletedPost Graduate Institute of Medical Education and Research, Chandigarh702019-11-012022-08-16
Mesenchymal Stem Cells After Renal or Liver Transplantation
Mesenchymal Stem Cells - Liver Failure, Kidney Failure
Phase 1 / Phase 2CompletedUniversity of Liege402012-02-012022-06-14
Single Pass Albumin Dialysis in Patients With Cirrhosis
Single pass albumin dialysis - Cirrhosis, Acute on Chronic Hepatic Failure
Phase 1 / Phase 2CompletedAssistance Publique - Hôpitaux de Paris112009-06-012015-02-25

Narrower conditions

Acute-On-Chronic Liver Failure (6)  ·  Fibrosis (2)  ·  Hepatic Encephalopathy (2)  ·  Brain Diseases (1)  ·  Brain Edema (1)  ·  Chemical and Drug Induced Liver Injury (1)  ·  Hepatorenal Syndrome (1)  ·  Kidney Diseases (1)  ·  Liver Diseases (1)  ·  Liver Failure (1)  ·  Neoplasms (1)  ·  Renal Insufficiency (1)

Broader conditions

Digestive System Diseases (7)  ·  Hepatic Insufficiency (7)  ·  Liver Diseases (6)  ·  Liver Failure (6)  ·  Central Nervous System Diseases (3)  ·  Nervous System Diseases (3)  ·  Brain Diseases (2)  ·  Brain Diseases, Metabolic (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Male Urogenital Diseases (2)  ·  Metabolic Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Pathologic Processes (2)

Interventions

Lactulose (2)  ·  Amino Acids (1)  ·  Amino Acids, Branched-Chain (1)

Sponsors

Post Graduate Institute of Medical Education and Research, Chandigarh (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Genfit (1)  ·  GuangZhou Cellgenes Biotechnology Co., Ltd. (1)  ·  Miromatrix Medical Inc. (1)  ·  University of Liege (1)

Countries

India (2)  ·  United States (2)  ·  Belgium (1)  ·  China (1)  ·  France (1)

Top investigators

Jack Lake, MD (1)  ·  Madhumita Premkumar, MD, DM (1)  ·  Yves Beguin, MD, PhD (1)

Results publications

PMID 25715177, PMID 28284916, PMID 30568347, PMID 37975059, PMID 6749458, PMID 818729